ProCE Banner Activity

My Take on Recent Data on the Metabolic Implications of Weight Gain Associated With ART

Conference Coverage
Clinical Thought
Weight gain has been associated with certain ARV regimens and new data show that this may lead to metabolic complications. How will these new data affect the way in which we treat and monitor patients with HIV? Here’s my take.

Released: April 14, 2020

Share

Faculty

Princy N. Kumar

Princy N. Kumar, MD

Professor of Medicine and Microbiology
Division of Infectious Diseases
Georgetown University Hospital
Division Chief
Division of Infectious Diseases and Travel Medicine
Department of Internal Medicine
Medstar Georgetown University Hospital
Washington, DC

Provided by

Provided by the USF Health
ProCE Banner

Supporters

This activity is supported by educational grants from

Gilead

Merck & Co., Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

Princy N. Kumar, MD

Professor of Medicine and Microbiology
Division of Infectious Diseases
Georgetown University Hospital
Division Chief
Division of Infectious Diseases and Travel Medicine
Department of Internal Medicine
Medstar Georgetown University Hospital
Washington, DC

Princy N. Kumar, MD, FIDSA, MACP, has disclosed that she has served on an advisory board/panel or speakers bureau for Amgen, Gilead Sciences, GlaxoSmithKline, Merck, and Theratechnologies; has received grants or research support for Gilead Sciences, GlaxoSmithKline, and Merck; and has ownership interest in Gilead Sciences, GlaxoSmithKline, Merck, Pfizer, and Johnson & Johnson.